Syneron Medical Ltd

Find Ratings Reports
ELOS : NASDAQ : Health Care
$10.45 -0.2 | -1.88%
Today's Range: 10.3501 - 10.625
Avg. Daily Volume: 315400.0
03/27/17 - 4:00 PM ET

Financial Analysis


SYNERON MEDICAL LTD's gross profit margin for the fourth quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. SYNERON MEDICAL LTD has strong liquidity. Currently, the Quick Ratio is 1.96 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year.

During the same period, stockholders' equity ("net worth") has remained unchanged from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q4 FY16 Q4 FY15
Net Sales ($mil)82.8978.89
EBITDA ($mil)6.95-2.5
EBIT ($mil)4.4-4.82
Net Income ($mil)-0.91.98


Balance Sheet Q4 FY16 Q4 FY15
Cash & Equiv. ($mil)67.970.96
Total Assets ($mil)276.57286.79
Total Debt ($mil)0.00.0
Equity ($mil)207.42209.21


Profitability Q4 FY16 Q4 FY15
Gross Profit Margin56.5658.09
EBITDA Margin8.38-3.17
Operating Margin5.31-6.11
Sales Turnover1.080.97
Return on Assets0.06-2.21
Return on Equity0.08-3.03
Debt Q4 FY16 Q4 FY15
Current Ratio2.92.59
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q4 FY16 Q4 FY15
Shares outstanding (mil)35.2835.28
Div / share0.00.0
EPS-0.030.05
Book value / share5.885.93
Institutional Own % n/a n/a
Avg Daily Volume310780.0163600.0

Valuation


HOLD. SYNERON MEDICAL LTD's P/E ratio indicates a significant premium compared to an average of 52.18 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 26.33. To use another comparison, its price-to-book ratio of 1.82 indicates a discount versus the S&P 500 average of 2.93 and a significant discount versus the industry average of 4.63. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
ELOS 1070.00 Peers 52.18   ELOS 45.15 Peers 25.34

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

ELOS is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

ELOS is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
ELOS 19.11 Peers 30.86   ELOS 0.26 Peers 1.14

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

ELOS is trading at a discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

ELOS trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
ELOS 1.82 Peers 4.63   ELOS 105.55 Peers 97.37

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

ELOS is trading at a significant discount to its peers.

 

Average. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

ELOS is expected to keep pace with its peers on the basis of earnings growth.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
ELOS 1.27 Peers 4.66   ELOS 7.28 Peers 14.44

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

ELOS is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

ELOS significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades